News
-
-
COMMUNIQUÉ DE PRESSE
Ondine Biomedical Inc. Announces Collaboration advances Steriwave for ICU Market
Ondine Biomedical partners with Royal Columbian Hospital Foundation's AIM division for clinical trials on Steriwave ICU use, aiming to reduce infections and improve patient outcomes in critical care settings -
-
-
COMMUNIQUÉ DE PRESSE
Communiqué : Orange annonce son intention de se retirer du NYSE, de se désenregistrer auprès de la Securities and Exchange Commission américaine et de solliciter l’accord des porteurs de certains titres de dette en circulation
Orange annonce son retrait du NYSE et de la SEC pour simplification interne et maintien de la transparence. ADR restera sur le marche OTC. Pas d'impact sur les clients -
COMMUNIQUÉ DE PRESSE
Press release: Orange intends to voluntarily delist from the NYSE, deregister with the SEC, and launch a consent solicitation in relation to certain outstanding notes
Orange intends to delist from NYSE, deregister with SEC, and launch consent solicitation for outstanding notes. Maintaining ADR program and aiming at internal simplification and efficiency -
-
-
-
COMMUNIQUÉ DE PRESSE
Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024.
Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9% in 1H 2024. Company showcases strong financial performance with new products and global expansion
